Light protection of the skin after photodynamic therapy reduces inflammation: an unblinded randomized controlled study

被引:32
作者
Petersen, B. [1 ]
Wiegell, S. R. [1 ]
Wulf, H. C. [1 ]
机构
[1] Univ Copenhagen, Dept Dermatol Res, Bispebjerg Hosp, DK-2400 Copenhagen, Denmark
关键词
METHYL AMINOLEVULINATE; ACTINIC KERATOSES; DAYLIGHT;
D O I
10.1111/bjd.12882
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Photodynamic therapy (PDT) is followed by significant inflammation. Protoporphyrin (Pp)IX is still formed in the skin after PDT and patients are sensitive to daylight 24-48 h after treatment. Exposure to daylight after PDT may therefore increase inflammation. Objectives To investigate whether protection with inorganic sunscreen, foundation or light-blocking plaster after PDT can reduce inflammation caused by daylight-activated PpIX. Methods On the right arm of 15 subjects with sun-damaged skin, four identical squares (3 x 3 cm) were given conventional PDT treatment. Immediately after red-light illumination the squares were either left unprotected or protected by inorganic sunscreen [sun protection factor (SPF) 50], foundation (SPF50) or light-blocking plaster. The skin was then illuminated with artificial daylight for 2 h and afterwards covered for 24 h. Fluorescence and erythema (inflammation) were measured with a fluorescence camera and a reflectance meter. Results PpIX was significantly reduced after artificial daylight illumination (P < 0.0004), except on the square protected with light-blocking silver plaster, where it had increased (P = 0.09). The increased erythema 24 h after treatment was reduced by 19% with the sunscreen (P = 0.29), by 27% with the foundation (P = 0.10) and by 44% with the silver plaster (P = 0.002). Conclusions Artificial daylight exposure after conventional PDT increases skin erythema. Light-blocking plaster gives more effective protection against post-PDT daylight exposure than inorganic sunscreen and foundation. In practice such full protection can be achieved by use of sun-blocking clothes or daylight avoidance for 24 h.
引用
收藏
页码:175 / 178
页数:4
相关论文
共 8 条
[1]   Phototoxic reaction and porphyrin fluorescence in skin after topical application of methyl aminolaevulinate [J].
Angell-Petersen, E. ;
Christensen, C. ;
Muller, C. R. ;
Warloe, T. .
BRITISH JOURNAL OF DERMATOLOGY, 2007, 156 (02) :301-307
[2]   Good agreement between minimal erythema dose test reactions and objective measurements: an in vivo study of human skin [J].
Bodekaer, Mette ;
Philipsen, Peter Alshede ;
Karlsmark, Tonny ;
Wulf, Hans Christian .
PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, 2013, 29 (04) :190-195
[3]   ENDOGENOUS PROTOPORPHYRIN-IX, A CLINICALLY USEFUL PHOTOSENSITIZER FOR PHOTODYNAMIC THERAPY [J].
KENNEDY, JC ;
POTTIER, RH .
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 1992, 14 (04) :275-292
[4]   Guidelines for topical photodynamic therapy: update [J].
Morton, C. A. ;
McKenna, K. E. ;
Rhodes, L. E. .
BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 (06) :1245-1266
[5]  
Renhua Na, 2001, J INVEST DERMATOL, V116, P536
[6]   Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses;: a randomized, controlled, single-blinded study [J].
Wiegell, S. R. ;
Haedersdal, M. ;
Philipsen, P. A. ;
Eriksen, P. ;
Enk, C. D. ;
Wulf, H. C. .
BRITISH JOURNAL OF DERMATOLOGY, 2008, 158 (04) :740-746
[7]   Photodynamic therapy of actinic keratoses with 8% and 16% methyl aminolaevulinate and home-based daylight exposure: a double-blinded randomized clinical trial [J].
Wiegell, S. R. ;
Haedersdal, M. ;
Eriksen, P. ;
Wulf, H. C. .
BRITISH JOURNAL OF DERMATOLOGY, 2009, 160 (06) :1308-1314
[8]  
Wulf HC, 1989, US Pat, P1, Patent No. [4,882,598, 4882598]